Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT07252739 |
| Title | KEYMAKER-U01 Substudy 01J: A Study of Pembrolizumab Plus MK-1084 in Participants With Non-Small Cell Lung Cancer (NSCLC) With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) G12C Mutations (MK-3475-01J/KEYMAKER-U01J) |
| Acronym | MK-3475-01J/KEYMAKER-U01J |
| Recruitment | Recruiting |
| Gender | both |
| Phase | Phase II |
| Variant Requirements | No |
| Sponsors | Merck Sharp & Dohme LLC |
| Indications | |
| Therapies | |
| Age Groups: | senior | adult |
| Covered Countries | USA |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Clermont Oncology Center ( Site 0041) | RECRUITING | Clermont | Florida | 34711 | United States | Details |
| Communal Noncommercial Enterprise "Podillia Regional Oncolog-Cardiothoracic department ( Site 0131) | RECRUITING | Vinnitsya | Vinnytsia Oblast | 21029 | Ukraine | Details |